Clinical Trial Update: Antireflux Ablation Therapy (ARAT) Vs Antireflux Mucosectomy (ARMS) In The Management Of Gastroesophageal Reflux Disease [NA]

View source ↗

Summary

A clinical trial evaluating Antireflux Ablation Therapy (ARAT) versus Antireflux Mucosectomy (ARMS) for gastroesophageal reflux disease has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroesophageal Reflux Disease

Snippet

Sponsor: Coordinación de Investigación en Salud, Mexico | Conditions: Gastroesophageal Reflux Disease | NA | Status: WITHDRAWN